{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:39:46Z","timestamp":1789079986809,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Meath Foundation at Tallaght Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the clinical impact of a fast-track PMR clinic to enable early diagnosis and treatment, and to define both patient and disease characteristics in newly diagnosed PMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Primary care physicians were invited to refer patients with new PMR to our fast-track clinic. Referral criteria included new onset shoulder or pelvic girdle pain and\/or stiffness with elevated inflammatory markers in patients over 50\u2009years. All patients were seen within 72\u2009h of referral. Patients with a rheumatology diagnosis of PMR had an US of their temporal and axillary arteries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>172 patients were referred from primary care over 12\u2009months. 39% of patients referred with suspected PMR had an alternative diagnosis for which PMR regimen glucocorticoids was inappropriate. 55% of the non-PMR diagnoses were other inflammatory rheumatological conditions requiring follow-up. Only 20% of patients referred from primary care already on glucocorticoids were commenced on bone protection. PMR patients were comorbid, with a mean of 2.5 other conditions. 75% of PMR patients experienced a glucocorticoid-related adverse event in the first 12\u2009months of treatment. 17% of patients with new PMR had US features of subclinical GCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The commencement of glucocorticoid therapy should be deferred until after specialist evaluation to enable an accurate clinical diagnosis. A delay in treatment can only realistically be avoided if general practitioners have access to a fast-track PMR clinic. We believe that rheumatologists should consider establishing fast-track PMR clinics and this study provides a strong case for and a template to support this practice innovation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae531","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:16:53Z","timestamp":1727421413000},"page":"3006-3011","source":"Crossref","is-referenced-by-count":15,"title":["Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-8322","authenticated-orcid":false,"given":"Sharon","family":"Cowley","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"School of Medicine, Trinity College Dublin , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-6454","authenticated-orcid":false,"given":"Patricia","family":"Harkins","sequence":"additional","affiliation":[{"name":"School of Medicine, Trinity College Dublin , Dublin,","place":["Ireland"]},{"name":"Department of Rheumatology, St James Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-6721","authenticated-orcid":false,"given":"Colm","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"School of Medicine, Trinity College Dublin , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3362","authenticated-orcid":false,"given":"Richard","family":"Conway","sequence":"additional","affiliation":[{"name":"School of Medicine, Trinity College Dublin , Dublin,","place":["Ireland"]},{"name":"Department of Rheumatology, St James Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5460-0965","authenticated-orcid":false,"given":"David","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"School of Medicine, Trinity College Dublin , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2025050316124348700_keae531-B1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"key":"2025050316124348700_keae531-B2","article-title":"Incidence and prevalence of polymyalgia rheumatica (PMR): the importance of the epidemiological context. The Italian Case","volume":"2019","author":"Manzo","journal-title":"Med Sci (Basel)"},{"key":"2025050316124348700_keae531-B3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025050316124348700_keae531-B4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"key":"2025050316124348700_keae531-B5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00259-020-04731-z","article-title":"Abnormalities at three musculoskeletal sites on whole-body positron emission tomography\/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity","volume":"47","author":"Owen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025050316124348700_keae531-B6","doi-asserted-by":"crossref","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025050316124348700_keae531-B7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025050316124348700_keae531-B8","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2025050316124348700_keae531-B9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jama.2020.10155","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"324","author":"Buttgereit","year":"2020","journal-title":"JAMA"},{"key":"2025050316124348700_keae531-B10","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316124348700_keae531-B11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316124348700_keae531-B12","first-page":"152260","article-title":"Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group","volume":"63","author":"Keller","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050316124348700_keae531-B13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316124348700_keae531-B14","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025050316124348700_keae531-B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025050316124348700_keae531-B16","doi-asserted-by":"crossref","first-page":"e000100","DOI":"10.1136\/rmdopen-2015-000100","article-title":"Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review","volume":"1","author":"Mackie","year":"2015","journal-title":"RMD Open"},{"key":"2025050316124348700_keae531-B17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N","article-title":"Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025050316124348700_keae531-B18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025050316124348700_keae531-B19","doi-asserted-by":"crossref","first-page":"105185","DOI":"10.1016\/j.jbspin.2021.105185","article-title":"Fast track clinic for early diagnosis of polymyalgia rheumatica: impact on symptom duration and prednisolone initiation","volume":"88","author":"Fr\u00f8lund","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2025050316124348700_keae531-B20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5114\/reum.2021.110600","article-title":"Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature","volume":"59","author":"Hysa","year":"2021","journal-title":"Reumatologia"},{"key":"2025050316124348700_keae531-B21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5114\/reum.2018.76900","article-title":"Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors\u2014a cohort study","volume":"56","author":"Manzo","year":"2018","journal-title":"Reumatologia"},{"key":"2025050316124348700_keae531-B22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050316124348700_keae531-B23","first-page":"1470","article-title":"Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae531\/60254415\/keae531.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3006\/60254415\/keae531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3006\/60254415\/keae531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:12:57Z","timestamp":1746288777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/3006\/7796565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,30]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae531","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,9,30]]}}}